吡格列酮治疗 3 个月可降低 2 型糖尿病患者循环 C1q 结合型脂联素复合物与总脂联素的比值，而体重指数无变化。
Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes.
机构信息
Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
出版信息
Diabetes Res Clin Pract. 2013 Jan;99(1):e14-7. doi: 10.1016/j.diabres.2012.10.003. Epub 2012 Nov 9.
Abstract
We measured circulating C1q-binding adiponectin (C1q-APN) levels before and after 3-month treatment with pioglitazone in people with type 2 diabetes. The results indicate 3-month treatment with pioglitazone reduces circulating levels of C1q-APN/total-adiponectin ratio without changes in body mass index.
摘要
我们在 2 型糖尿病患者接受吡格列酮治疗 3 个月前后测量了循环 C1q 结合脂联素（C1q-APN）水平。结果表明，吡格列酮治疗 3 个月可降低循环 C1q-APN/总脂联素比值，而体重指数无变化。
Zotero 插件